UK markets open in 6 hours 48 minutes
NIKKEI 225
31,759.88 0.00 (0.00%) HANG SENG
17,809.66 +436.66 (+2.51%) CRUDE OIL
88.53 -0.29 (-0.33%) GOLD FUTURES
1,840.30 -6.90 (-0.37%) DOW
33,433.35 -74.15 (-0.22%) Bitcoin GBP
22,782.15 -355.84 (-1.54%)
Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.87 |
| Open | 26.52 |
| Bid | 25.70 x 1400 |
| Ask | 26.96 x 800 |
| Day's range | 25.94 - 26.69 |
| 52-week range | 23.09 - 42.48 |
| Volume | |
| Avg. volume | 895,857 |
| Market cap | 2.814B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders since they're up 99% over 5 years
It hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders, since the share price...
- Simply Wall St.
After a year of 4.1% returns, Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) share price drop last week may have less of an impact on institutional investors
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...
- Simply Wall St.
Arrowhead Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations
Arrowhead Pharmaceuticals ( NASDAQ:ARWR ) Second Quarter 2023 Results Key Financial Results Revenue: US$146.3m (down...
© 2023 Yahoo. All rights reserved.
